AXS Investments »

Cardiol Therapeutics Inc- foreign shares owned by AXS Investments

Quarter-by-quarter ownership of Cardiol Therapeutics Inc- foreign (CRDL) shares owned by AXS Investments from 13F filings

Historical chart of AXS Investments investment in Cardiol Therapeutics Inc- foreign

Tip: Access up to 7 years of quarterly data

All positions including Cardiol Therapeutics Inc- foreign held by AXS Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardiol Therapeutics Inc- foreign by AXS Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $579k 698k 0.83
2023-09-30 $706k 774k 0.91
2023-06-30 $1.2M 1.3M 0.89
2023-03-31 $844k 1.7M 0.49

More positions owned by AXS Investments

Alphabet Inc-cl A Equity (GOOGL)
Meta Platforms Common (META)
Microsoft Corp Common (MSFT)
Visa Inc-class A Shares Equity (V)
Salesforce Common (CRM)
Mastercard Inc Cl A Common (MA)
Netflix Equity (NFLX)
Accenture Plc-cl A Equity (ACN)
Adobe Common (ADBE)
Servicenow Common (NOW)
Intuit Common (INTU)
Oracle Corp Common (ORCL)
Apple Common (AAPL)
Nvidia Corp Common (NVDA)
Intl Business Machines Corp Common (IBM)

View all positions for AXS Investments

Top funds holding Cardiol Therapeutics Inc- foreign

MMCAP International Inc. SPC
Tejara Capital
AXS Investments
Lion Street Advisors
Cambridge Investment Research Advisors
Bank Of Montreal
We Are One Seven
Credit Suisse
Advisor Group Holdings
Marble Harbor Investment Counsel
Royal Bank of Canada
Goldman Sachs Group
Two Sigma Advisers
Private Ocean
Citadel Advisors

View all funds holding Cardiol Therapeutics Inc- foreign